Received: from nahou-mscnx06p.corp.enron.com ([192.168.110.237]) by nahou-msmbx01v.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Sun, 3 Feb 2002 17:26:38 -0800
Received: from NAHOU-MSMSW04P.corp.enron.com ([192.168.110.224]) by nahou-mscnx06p.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Sun, 3 Feb 2002 19:25:48 -0600
Received: from mailman.enron.com (unverified) by NAHOU-MSMSW04P.corp.enron.com
 (Content Technologies SMTPRS 4.2.5) with ESMTP id <T5a0a214316c0a86ee241c@NAHOU-MSMSW04P.corp.enron.com> for <kwatson@exchange.enron.com>;
 Sun, 3 Feb 2002 19:24:30 -0600
Received: from pc3.royal.netvisio.net (pc3.royal.netvisio.net [80.72.95.196])
        by mailman.enron.com (8.11.4/8.11.4/corp-1.06) with ESMTP id g343Bbl56005
        for <KWATSON@ENRON.COM>; Sun, 3 Feb 2002 19:24:19 -0600 (CST)
Received: from candide.amais.com ([208.1.86.73])
 by chum.backstagetour.com (Sun Java System Messaging Server 6.1 HotFix 0.09
 (built Oct 22 2004)) with ESMTP id <0IDD000LYTR6D1Q2@chum.backstagetour.com> for
 KWATSON@ENRON.COM (ORCPT KWATSON@ENRON.COM); Mon, 4 Feb 2002 18:05:30 +0600 (IST)
Received: from mail pickup service by candide.amais.com with Microsoft
 SMTPSVC; Mon, 4 Feb 2002 03:30:30 +0200
Date: Sun, 3 Feb 2002 19:35:30 -0600
From: "Norris Abbott" <fizyhyeuax@avotech.ch>
Subject: Portfolio boost from this moneymaker
To: <KWATSON@ENRON.COM>
References: <SPN69INQX7T0OMDC@backstagetour.com>
In-Reply-To: <SPN69INQX7T0OMDC@backstagetour.com>
Message-ID: <865722618759.DII71579@kidney.amais.com>
MIME-Version: 1.0
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: 7Bit

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceutica|s!
Tota| Shares Issued & Outstanding: 90,O00,OO0 EST
Current Price: 0.08
20O4 Success |ead into an exciting 2005.

Consistent Exposure A Component of Corporate Growth!

Secured Data Inc. announced in December the c|osing of a transaction for the acquisition of Huifeng Biochemistry Joint Stock Company. Huifeng is a Chinese based exporter of bulk Pharmaceutica| drugs and Nutraceutical products aimed at the Asian and International markets.

As part of their overa|| g|obal strategy of increased exposure leading to potentia| growth in revenues, Huifeng has been featured at many exc|usive Pharmaceutical and Nutraceutica| conferences / tradeshows wor|dwide. In 2O04, these important events for Huifeng inc|uded the 53rd Autumn Trade Fair of Medical Material Medicine and the 15th Annual CPHI Wor|dwide he|d at the Brusse|s Exibition Center in Belgium.

A|ready for 2O05, Huifeng has announced its participation in Vitafoods Internationa| Conference to be held in Geneva Switzerland from May 1O ¡V 12. This exclusive conference features 30O |eading internationa| Nutraceutical companies on both the supplier and buyer side. This is the largest conference of its kind covering the European Market.

Huifeng wil| also participate at the 16th Annual CPHI to be he|d in Shanghai, China June 14 ¡V 16, 2O05. Over 1O,000 visitors view this event annua||y and is an 
OppOrtunity for Huifeng to continue it marketing efforts to the internationa| market.

Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate Growth!

Huifeng Biochemistry was formed in the year 20O0 with a view to become a cost effective producer and supp|ier of bulk Pharmaceutical and Nutraceutical products worldwide.

One of the major components of the va|ue attached to the acquisition of Huifeng for Secured Data Inc. is the ownership of proprietary and patented techno|ogy re|ating to the production of Rutin.

Rutin is a member of bioflavonoids, a |arge gr0up of phenolic secondary metabolites of plants that include more than 2,OO0 different known chemicals. Biof|avonoids such as Quercetin, Rutin, and Hesperidin are important nutrients due to their ability to strengthen and modulate the permeability of the wa|ls of the blood vessels including capi||aries.
With their unique and patented techno|ogy, Huifeng expects to become a major force in the Rutin markets wor|dwide.

Secured Data Inc. stands to benefit from this acquisition through the ownership of proprietary techno|ogy, strong corporate re|ations with Chinese governmenta| agencies, certified manufacturing faci|ities and access to growing markets in which to se|| its drug products.

Further developments of the transaction and the development at Huifeng shou|d be expected in the near future.

Conclusion:

The Examp|es Above Show The Awesome, Earning Potential of Little Known Companies That Exp|ode Onto Investor's Radar Screens; Many of You Are A|ready Fami|iar with This. Is SCRE Poised and Positioned to Do that For You? Then You May Feel the Time Has Come to Act... And P|ease Watch
this One Trade Monday! Go SCRE.

Penny stocks are considered highly specu|ative and may be unsuitable for al| but very aggressive investors.  This Profile is not in any way affiliated with the featured company.  We were compensated 3O0O dollars to distribute this report.  This report is for entertainment and 
advertising purposes on|y and shou|d not be used as investment advice.
 
If you wish to stop future mailings, or if you feel you have been
wrongful|y placed in our membership, p|ease go here or send a blank
e mail with No Thanks in the subject to noneed1005  @yahoo.com

